- FTC and Justice Department to Hold Two-Day Virtual Public Workshop Examining Antitrust Enforcement in the Pharmaceutical Industry ( )
- FTC Acts to Protect Patients Who Rely on Medical Instruments Used in Sinus Procedures ( )
- Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug ( )
- Statement of Federal Trade Commission Bureau of Competition Deputy Director John M. Newman on Federal Appeals Court Ruling Affirming Preliminary Injunction to Halt Merger of New Jersey Hospital Networks ( )
- Statement Regarding Termination of Attempted Merger of Rhode Island’s Two Largest Healthcare Providers ( )
- FTC Approves Modifications to Boston Scientific Corp. Divestiture Agreement ( )
- FTC and Rhode Island Attorney General Step in to Block Merger of Rhode Island’s Two Largest Healthcare Providers ( )
- FTC Comment to Food and Drug Administration Supports Agency’s Proposed Rule on Establishing Over-the-Counter Hearing Aids ( )
- Vision Path, Inc., Online Seller of Hubble Lenses, Settles Charges it Violated the Contact Lens Rule and FTC Act to Boost Sales ( )
- With Omicron Variant on the Rise, FTC Orders More Marketers to Stop Falsely Claiming Their Products Can Effectively Prevent or Treat COVID-19 ( )
- Statement of Chair Lina M. Khan on the Ruling by Judge Denise L. Cote Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al ( )
- FTC Approves Final Order Imposing Strict Limits on Future Mergers by Dialysis Service Provider DaVita, Inc. ( )
- FTC Approves Final Order Requiring Alabama Board of Dental Examiners to Stop Unreasonably Excluding Lower Cost Online and Teledentistry Providers from Competing ( )
- FTC, States to Recoup Millions in Relief for Victims Fleeced by ‘Pharma Bro’ Scheme to Illegally Monopolize Life-Saving Drug Daraprim ( )
- FTC Imposes Strict Limits on DaVita, Inc.’s Future Mergers Following Proposed Acquisition of Utah Dialysis Clinics ( )
- Alabama Board of Dental Examiners Agrees to Settle FTC Charges that It Unreasonably Excluded Lower Cost Online and Teledentistry Providers from Competition ( )
- FTC Warns Health Apps and Connected Device Companies to Comply With Health Breach Notification Rule ( )
- FTC Staff Opinion with Respect to Doylestown Health Physicians ( )
- Public Access to Illumina/Grail Trial Provided via Teleconference Due to ongoing COVID-19 Concerns ( )
- Statement of FTC Office of Public Affairs Director Lindsay Kryzak on District Court’s Decision to Grant Preliminary Injunction Halting New Jersey Hospital Merger ( )
- Refunds Coming to Consumers Who Bought Deceptively Marketed Willow Curve Device ( )
- Federal Trade Commission Withdraws Remaining Case against AbbVie after Supreme Court Decision Strips Consumers of Relief ( )
- FTC Finalizes Order with Flo Health, a Fertility-Tracking App that Shared Sensitive Health Data with Facebook, Google, and Others ( )
- Promoter of $23,000 COVID-19 “Treatment” Plan Barred from Making Bogus Health Claims ( )
- Federal Trade Commission Sends Report to Congress on Rebate Walls ( )
- Statement of FTC Acting Bureau of Competition Director Maribeth Petrizzi on Bureau’s Motion to Dismiss Request for Preliminary Relief in Illumina/GRAIL Case ( )
- Multilateral Pharmaceutical Merger Task Force Seeks Public Input ( )
- FTC Returns Nearly $60 Million to Those Suffering from Opioid Addiction Who Were Allegedly Overcharged in Suboxone Film Scheme ( )
- U.S. Court of Appeals for the Fifth Circuit Upholds FTC’s Opinion against Generic Pharmaceutical Company Impax Laboratories, LLC ( )
- FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.